Help | RSS Feed

Mateon Therapeutics, Inc. (OTCMKT:MATN) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Mateon Therapeutics, Inc. (OTCMKT:MATN) seasonal charts above shows that a Buy Date of December 22 and a Sell Date of March 13 has resulted in a geometric average return of 9.18% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 12 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 109.18% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Mateon Therapeutics Inc is a US-based biopharmaceutical company which is focused on the development of vascular disrupting agents (VDA), for the treatment of cancer. VDA targets the vasculature of cancer tumors and obstructs a tumor’s blood supply without disrupting the blood supply to normal tissues. The company is engaged in developing clinical stage investigational drugs that is CA4P and OXi4503. CA4P s a reversible tubulin-binding agent that selectively targets endothelial cells, which make up the interior lining of blood vessel walls in solid tumors; and OXi4503 which is a novel, dual-mechanism VDA, to reduce tumor blood flow and it also forms a potentially anti-proliferative metabolite.

To download MATN seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore